Company Data
Centessa Pharmaceuticals plc
Ticker
CNTA
Current Price
$16.63 -0.72%
Market Cap
$2.2B
Price Target
Refer to Report
Volume
740.0K
52wk Range
$7.75 - $19.09
Overview
Centessa Pharmaceuticals PLC is a pharmaceutical company. Its portfolio consists of preclinical to phase 3 uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Some of its products include Vasopressin V2 Receptor Inhibitor (Lixivaptan), BMP9 Engineered Variant (MGX292), OX2R Agonist (Oral) among others.